These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22669581)

  • 1. [Fixed drug eruption in dermatology setting in Lomé (Togo): a retrospective study of 321 cases].
    Saka B; Kombaté K; Médougou BH; Akakpo S; Mouhari-Toure A; Boukari T; Tchangaï-Walla K; Pitché P
    Bull Soc Pathol Exot; 2012 Dec; 105(5):384-7. PubMed ID: 22669581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-year-analysis of fixed drug eruptions in hospital settings in France.
    Brahimi N; Routier E; Raison-Peyron N; Tronquoy AF; Pouget-Jasson C; Amarger S; Machet L; Amsler E; Claeys A; Sassolas B; Leroy D; Grange A; Dupuy A; Cordel N; Bonnetblanc JM; Milpied B; Doutre MS; Guinnepain MT; Barbaud A; Chosidow O; Roujeau JC; Lebrun-Vignes B; Descamps V
    Eur J Dermatol; 2010; 20(4):461-4. PubMed ID: 20507840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P
    Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral mucosal fixed drug eruption: characteristics and differential diagnosis.
    Özkaya E
    J Am Acad Dermatol; 2013 Aug; 69(2):e51-8. PubMed ID: 23044075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Boukari T; Pitché P; Tchangaï-Walla K
    Med Trop (Mars); 2011 Apr; 71(2):162-4. PubMed ID: 21695874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Self-medication for dermatologic conditions in Lomé, Togo].
    Mouhari-Toure A; Kombaté K; Saka B; Akakpo S; Boukari OB; Pitche P; Tchangaï-Walla K
    Med Trop (Mars); 2010 Jun; 70(3):303-4. PubMed ID: 20734605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug related clinical pattern in fixed drug eruption.
    Ozkaya-Bayazit E; Bayazit H; Ozarmagan G
    Eur J Dermatol; 2000 Jun; 10(4):288-91. PubMed ID: 10846256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fixed drug eruptions due to cotrimoxazole.
    Miah MA; Ahmed SS; Chowdhury SA; Begum F; Rahman SH
    Mymensingh Med J; 2008 Jul; 17(2 Suppl):S1-5. PubMed ID: 18946439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cutaneous drug eruption at hospital in Bamako].
    Konaré HD; Cissé IA; Oumar AA; Idrissa S; Maiga S; Dao S; Rhaly A; Tounkara A
    Mali Med; 2012; 27(1):57-61. PubMed ID: 22766040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug eruptions in children in Cotonou, Benin].
    Adegbidi H; Atadokpede F; Sagbo G; Koudoukpo C; D'Almeida M; Teclessou J; N'Dah P; Djoonyam A Eroume AT; Yedomon HG; Do Ango-Padonou F
    Mali Med; 2012; 27(1):42-6. PubMed ID: 22947321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed drug eruption: topical provocation and subsequent phenomena.
    Mahboob A; Haroon TS; Iqbal Z; Iqbal F; Saleemi MA; Munir A
    J Coll Physicians Surg Pak; 2006 Dec; 16(12):747-50. PubMed ID: 17125631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [AIDS related Kaposi sarcoma: 103 cases in dermatology in Lomé (Togo)].
    Saka B; Mouhari-Toure A; Wateba IM; Akakpo S; Kombaté K; Balaka A; Sogan A; Afolabi KO; Pitché P; Tchangaï-Walla K
    Med Sante Trop; 2013; 23(1):109-11. PubMed ID: 23692859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leprosy in Lome, Togo: retrospective study of 383 cases].
    Saka B; Kombate K; Mouhari-Toure A; Amegan-Aho KH; Tchangai-Walla K; Pitche P
    Med Trop (Mars); 2008 Oct; 68(5):496-8. PubMed ID: 19068982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fixed drug eruption : about 13 cases].
    Daoud W; Zeglaoui F; Kastalli S; Elfekih N; Fazaa B; Loueslati M; Belkahia C; Kamoun MR
    Tunis Med; 2007 Jan; 85(1):39-41. PubMed ID: 17424708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patch testing in fixed drug eruptions--a 20-year review.
    Andrade P; Brinca A; Gonçalo M
    Contact Dermatitis; 2011 Oct; 65(4):195-201. PubMed ID: 21702758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scleroderma in a hospital setting in Togo].
    Pitche P; Amanga Y; Koumouvi K; Oniankitan O; Mijiyawa M; Tchangaï-Walla K
    Med Trop (Mars); 1998; 58(1):65-8. PubMed ID: 9718559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update of fixed drug eruptions in Singapore.
    Heng YK; Yew YW; Lim DS; Lim YL
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1539-44. PubMed ID: 25491106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption.
    Ben Fadhel N; Chaabane A; Ammar H; Ben Romdhane H; Soua Y; Chadli Z; Zili J; Boughattas NA; Ben Fredj N; Aouam K
    Contact Dermatitis; 2019 Nov; 81(5):336-340. PubMed ID: 31291002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing.
    Tornero P; De Barrio M; Baeza ML; Herrero T
    Contact Dermatitis; 2004 Aug; 51(2):57-62. PubMed ID: 15373844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous adverse drug reactions in children. A series of 90 cases.
    Khaled A; Kharfi M; Ben Hamida M; El Fekih N; El Aidli S; Zeglaoui F; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2012 Jan; 90(1):45-50. PubMed ID: 22311448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.